Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Appointed CFO
Quarterly results
Appointed director
CC transcript
Credit agrmnt [a]
WALGREEN CO (WAG) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/31/2014 8-K Quarterly results
12/29/2014 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Walgreens Shareholders Approve All Proposals Related to Transaction with Alliance Boots and Holding Company Reorganization DEERFIELD, Ill., Dec. 29, 2014 - At a special meeting of shareholders held today, Walgreens shareholders voted to approve all proposals related to the company's acquisition of the remaining 55 percent of Alliance Boots GmbH that it does not currently own and the reorganization of the company into a holding company structure. Approximately 97 percent of the votes cast were in favor of the reorganization proposal , and approximately 97 percent of the votes cast were in favor of the share issuance proposal. The transaction will fully combine the two companies to form the first global pharmacy-led, health and wellbeing enterprise. The companies launched a long-term strate..."
12/23/2014 8-K Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T...
Docs: "Amendment No. 1 dated December 23, 2014, to the Agreement and Plan of Merger, by and among Walgreen Co., Walgreens Boots Alliance, Inc., and Ontario Merger Sub, Inc",
"Revolving Credit Agreement, among Walgreen Co., Walgreens Boots Alliance, Inc., the lenders from time to time party thereto and Mizuho Bank, Ltd., as administrative agent",
"Form of Restricted Stock Unit Agreement, as amended (Special Transition Awards)",
"Walgreens Announces Intention to List Walgreens Boots Alliance Shares on Nasdaq Following Completion of Holding Company Reorganization"
12/23/2014 8-K Quarterly results
Docs: "Walgreen Co. Reports Fiscal 2015 First Quarter Results"
12/10/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "WALGREENS PRESIDENT AND CEO GREG WASSON ANNOUNCES HE WILL RETIRE FOLLOWING COMPLETION OF MERGER WITH ALLIANCE BOOTS"
12/03/2014 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Walgreens November Sales Increase 4.9 Percent DEERFIELD, Ill., Dec. 3, 2014 - Walgreens had November sales of $6.36 billion, an increase of 4.9 percent from $6.06 billion for the same month in fiscal 2014. Total front-end sales increased 1.3 percent compared with the same month in fiscal 2014, while comparable store front-end sales increased 0.8 percent. Customer traffic in comparable stores decreased 3.3 percent while basket size increased 4.1 percent. Prescriptions filled at comparable stores increased by 2.6 percent in November and increased 4.6 percent on a calendar day-shift adjusted basis. This year's November had one additional Sunday and one fewer Friday compared with November 2013. These calendar shifts negatively impacted prescriptions filled at comparable stores by 2.0 percenta..."
11/20/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Form of 2.875% Notes due 2020",
"Form of 3.600% Notes due 2025",
"Form of 2.125% Notes due 2026",
"Form of Guarantee of Walgreen Co",
"Opinion of Wachtell, Lipton, Rosen & Katz",
"Opinion of Thomas J. Sabatino, Jr"
11/18/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Indenture among Walgreens Boots Alliance, Inc. and Wells Fargo Bank, National Association, as trustee",
"Form of Floating Rate Notes due 2016",
"Form of 1.750% Notes due 2017",
"Form of 2.700% Notes due 2019",
"Form of 3.300% Notes due 2021",
"Form of 3.800% Notes due 2024",
"Form of 4.500% Notes due 2034",
"Form of 4.800% Notes due 2044",
"Form of Guarantee of Walgreen Co",
"Opinion of Wachtell, Lipton, Rosen & Katz"
11/12/2014 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
Docs: "Underwriting Agreement, by and among Walgreen Co., Walgreens Boots Alliance, Inc., and Goldman, Sachs & Co., Deutsche Bank Securities Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representatives of the several other underwriters named therein",
"Underwriting Agreement, by and among Walgreen Co., Walgreens Boots Alliance, Inc., and Goldman, Sachs & Co., Deutsche Bank AG, London Branch, Merrill Lynch International, HSBC Bank plc, J.P. Morgan Securities plc, Morgan Stanley & Co. International plc, Wells Fargo Securities, LLC, Mitsubishi UFJ Securities International plc, Société Générale, The Royal Bank of Scotland plc, UniCredit Bank AG, U.S. Bancorp Investments, Inc., Banca IMI S.p.A., Lloyds Bank plc, Mizuho International plc, Santander S.A. and SMBC Nikko Capital Markets Limited",
"Term Loan Credit Agreement, among Walgreen Co., Walgreens Boots Alliance, Inc., the lenders from time to time party thereto, and Bank of America, N.A., as administrative agent",
"Revolving Credit Agreement, among Walgreen Co., Walgreens Boots Alliance, Inc., the lenders from time to time party thereto and Bank of America, N.A., as administrative agent"
11/03/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Unaudited Pro Forma Consolidated Financial Information"
09/30/2014 8-K Quarterly results
Docs: "Walgreen Co. Reports Fiscal 2014 Fourth Quarter and Full-Year Results"
09/26/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Notice of Pendency and Settlement of Shareholder Derivative Action",
"Stipulation and Agreement of Settlement"
09/16/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Unaudited Pro Forma Consolidated Financial Information"
09/08/2014 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Nomination and Support Agreement, between JANA Partners LLC and Walgreen Co",
"Walgreens Appoints Barry Rosenstein of JANA Partners LLC to Board of Directors As Company Progresses Toward Alliance Boots Merger"
09/04/2014 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Walgreens August Sales Increase 3.6 Percent"
08/08/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Retirement Agreement and Release between Walgreen Co. and Kermit C. Crawford",
"Consulting Services Agreement between Walgreen Co. and Kermit C. Crawford",
"Form of Restricted Stock Unit Award agreement",
"Form of Performance Share Award agreement",
"Form of Stock Option Award agreement"
08/06/2014 8-K Entry into a Material Definitive Agreement, Cost Associated with Exit or Disposal Activities, Material Impairments, Unregiste...
Docs: "Amendment No. 1, to the Purchase and Option Agreement and Walgreen Co. Shareholders Agreement, by and among Walgreen Co., Alliance Boots GmbH, AB Acquisitions Holdings Limited, Walgreen Scotland Investments LP, KKR Sprint (European II) Limited, KKR Sprint (2006) Limited and KKR Sprint (KPE) Limited, Alliance Santé Participations S.A., Stefano Pessina and Kohlberg Kravis Roberts & Co. L.P",
"Walgreen Co. investor presentation",
"Transcript of Walgreen Co. August 6, 2014 conference call",
"Walgreens Board of Directors Exercises Option to Complete Second Step of Strategic Partnership with Alliance Boots and Fully Combine Both Companies, Creating First Global Pharmacy-Led, Health and Wellbeing Enterprise"
08/04/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Offer letter agreement between Timothy R. McLevish and Walgreen Co",
"Transition and Separation Agreement with Wade D. Miquelon"
07/24/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/24/2014 8-K Quarterly results
Docs: "Walgreen Co. Reports Fiscal 2014 Third Quarter Results"
05/15/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Consent of KPMG LLP",
"Alliance Boots GmbH audited consolidated financial statements"
03/25/2014 8-K Quarterly results
Docs: "Walgreen Co. Reports Fiscal 2014 Second Quarter Results"
03/07/2014 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Walgreens February Sales Increase 5.0 Percent DEERFIELD, Ill., March 5, 2014 - Walgreens had February sales of $6.05 billion, an increase of 5.0 percent from $5.76 billion for the same month in fiscal 2013. Total front-end sales increased 3.0 percent compared with the same month in fiscal 2013, while comparable store front-end sales increased 2.0 percent. Customer traffic in comparable stores decreased 0.7 percent while basket size increased 2.7 percent. Prescriptions filled at comparable stores increased by 2.2 percent in February. Prescriptions filled at comparable stores were positively impacted by 0.1 percentage point due to more flu shots in the month versus last year but were negatively impacted by 1.0 percentage point due to the lower incidence of flu in February 2014. February pha..."
01/14/2014 8-K Submission of Matters to a Vote of Security Holders
12/20/2013 8-K Quarterly results
Docs: "Walgreen Co. Reports Fiscal 2014 First Quarter Results"
12/04/2013 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Walgreens November Sales Increase 4.1 Percent DEERFIELD, Ill., Dec. 4, 2013 - Walgreens had November sales of $6.07 billion, an increase of 4.1 percent from $5.83 billion for the same month in fiscal 2013. Total front-end sales increased 3.2 percent compared with the same month in fiscal 2013, while comparable store front-end sales increased 1.9 percent. Customer traffic in comparable stores increased 0.8 percent while basket size increased 1.1 percent. The company said that a meaningful increase versus prior quarters in promotional investment contributed to the improvement in traffic and comparable store front-end sales for November and throughout the quarter. Prescriptions filled at comparable stores increased by 1.4 percent in November and increased 3.7 percent on a calendar day-shift ..."
10/01/2013 8-K Form 8-K - Current report
09/05/2013 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Walgreens August Sales Increase 5.6 Percent DEERFIELD, Ill., Sept. 5, 2013 - Walgreens had August sales of $6.17 billion, an increase of 5.6 percent from $5.84 billion for the same month in fiscal 2012. Total front-end sales increased 3.9 percent compared with the same month in fiscal 2012, while comparable store front-end sales increased 2.2 percent. Customer traffic in comparable stores decreased 1.5 percent while basket size increased 3.7 percent. Prescriptions filled at comparable stores increased by 5.6 percent in August and increased 7.4 percent on a calendar day-shift adjusted basis. This year's August had one additional Saturday and one fewer Wednesday compared with August 2012. These calendar shifts negatively impacted prescriptions filled at comparable stores by 1.8 percentage p..."
06/25/2013 8-K Form 8-K - Current report
05/07/2013 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Walgreens Announces Alliance Boots to Release Year-End Results on May 15"
03/19/2013 8-K Quarterly results
Docs: "Walgreen Co. Reports Fiscal 2013 Second Quarter Results",
"WALGREENS AND ALLIANCE BOOTS ANNOUNCE STRATEGIC, LONG-TERM RELATIONSHIP WITH AMERISOURCEBERGEN"
03/06/2013 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Walgreens February Sales Decrease 2.2 Percent"
01/14/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Walgreen Co. 2013 Omnibus Incentive Plan",
"Form of Restricted Stock Unit Award agreement(effective January 10, 2013)",
"Form of Performance Share Award agreement (effective January 10, 2013)",
"Form of Stock Option Award agreement (effective January 10, 2013)",
"Amendment to Walgreen Co. Executive Deferred Profit-Sharing Plan"
09/28/2012 8-K Quarterly results
Docs: "Fiscal Year 2012 Summary Financial Results GAAP FY11 FY12 Change Net Sales $72,184 $71,633 Operating Income $4,365 $3,464 Net Earnings $2,714 $2,127 Diluted net earnings per share $2.94 $2.42 Operating Cash Flow $3,643 $4,431 21.6% Non-GAAP* FY11 FY12 Change Supplemental Adjusted Operating Income* $4,358 $4,097 Supplemental Adjusted Net Earnings* $2,710 $2,565 Supplemental Adjusted Diluted net earnings per share* $2.93 $2.93 0.0% * Refer to the supplemental information presented below for reconciliations of the supplemental non-GAAP financial measures used in this release to the most comparable GAAP financial measure and related disclosures. During fiscal 2012, the company returned more than $1.9 billion to shareholders through dividends and share repurchases. The company also delivered re..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy